Member Info for Retireby40

Now gone 3v1 so primed to move higher. Was 1v3 at open. Onwards and upwards.

Love this -

PepsiCo tested the Mirriad concept on eight Univision telenovelas, according to Brady, initially focusing on the Pepsi brand before broadening use cases to Quaker, Lay's and Mountain Dew. The company is now in discussions to bring Mirriad's tech to its Latin American and European markets.

"Because it's digitally inserted, we can adapt the creative," Brady said. "If it's an older piece of content, it might be an older package; this offers us the opportunity to update the assets to be very current and to the right message that we're trying to speak to now, and ideally, to be able to serve specific messages based on targeting cues as well."

In the same way that startups lend PepsiCo outside know-how needed to navigate a fast-changing market, PepsiCo can give fledgling businesses greater reach and exposure that would otherwise be difficult to achieve.

"One of the bigger challenges of working with a partner like Mirriad is they're still a nascent technology and they need help building out their content slate," Brady said. "They were able to bring to us the relationship that they had built with Univision, but as we look to continue to scale this, we've brought and made those relationship connections with some of our bigger partners."

I’m amazed we are not higher. Clearly a lot going on snd once these large cos come on board the number of opportunities to work with them will increase exponentially. Am surprised another Tier 1 hasn’t signed up yet, only a matter of time surely.

I can answer that. Clinical validation is not in his hands and many stakeholders involved.

A fair bit in the media about false positives and how LFTs are not fit for purpose. To be fair Alastair has always highlighted the importance of a test having very high specificity to ensure LFTs are not meaning those not infected are isolating. Hopefully the initial data is backed up and then I imagine they’ll go on a PR push with rock solid data and get out test out there.

Importantly, out of a total of 26 negative samples tested with the lateral flow device, the test correctly identified all 26 as negative, giving a clinical specificity of 100%. High specificity is critical for a lateral flow test for mass screening so that large numbers of false positives are not generated which would create a major burden on follow-on testing resources, and result in a significant socio-economic cost of unnecessarily isolating people.

https://science.sciencemag.org/content/370/6515/eabd4585.long

A mere gentle reminder. We are testing for effectiveness against Covid-19 but we also hope it to be a generic antiviral as well as of course COPD.

From MARKinvestor on advfn guild -

COPD Market Set to Hit $14.1 Billion by 2025

The chronic obstructive pulmonary disease (COPD) space across the eight major markets of the US, France, Germany, Italy, Spain, the UK, Japan, and Australia, is set to rise from $9.9 billion in 2015 to around $14.1 billion by 2025, representing a compound annual growth rate of 3.7%, according to research and consulting firm GlobalData.

Signed. 518 now.

4 vs 1 so 34p going soon.

Ha, if only!

Some people live in the past, many try to live in the present but some of us of LSE live a couple of mins in the future!

Great post, Schrow and completely agree.

Paul, sorry for the delay was a boozy one yesterday.

No idea re 100ks and as pointed out they could also be buys given the uptick in share price.

I said circa £7m in orders not revenue as last year we announced £2m in orders (and as interim showed £1m revenue H1). For whatever reason I assume they’ll only upgrade the £10m forecast once they have confirmed orders (different to last year) or they would have done so already. They expect triple digit YoY growth so at least £8.8m and we have £3.6m in MWG orders and more to come I’m sure.

Anyway, a decent buy RNS today and hopefully news isn’t too far away on skintrustclub but more importantly for me the PD testing in China and elsewhere.

Someone/entity is doing well selling 100k lots. The quicker they’re cleared the better. Hopefully before good news lands.

Huh, 50k buyer and 100k seller. Nice volume. 1v3, be good to clear 34p

Haven’t seen such a positive start here for a while. Long may it continue.

This board is being clogged up and all samey so I’ll post the same again.

Exactly, more positive safety data key.

If the home trial results are positive albeit not nearly as conclusive as hospital and of course safe it’s fantastic. It will illustrate it’s effective early and late in being administered and putting fires out. So many independent papers have also been published re interferon beta and remember it’s likely to be effective not just for Covid-19 but many viruses so a generic therapeutic and of course there’s the original target COPD.

The science is overwhelmingly behind what SNG001 delivers and of course how it’s delivered.

One example of a paper -

https://link.springer.com/content/pdf/10.1007/s00134-021-06392-4.pdf

https://amp.theguardian.com/world/2021/apr/11/canada-ski-resort-p1-covid-variant-whistler?utm_term=Autofeed&CMP=twt_gu&utm_medium=&utm_source=Twitter&__twitter_impression=true

Given the faff and how uncomfortable getting a proper sample is surely ours will be a self-administered one too. Crazy otherwise.